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anti-malarial drugs in China”The winning of the 2015 Nobel Prize in Physiology or Medicine by
William C. Champbell, Satoshi Omura, and the Chinese scientist
Youyou Tu marks their pioneering discoveries of novel therapeutic
drugs to treat highly devastating parasitic diseases that mostly
affect the world’s poorest populations, such as river blindness,
lymphatic ﬁlariasis, and malaria. More appreciably, this is also the
ﬁrst time that a Chinese scientist was awarded this Noble Prize.
Professor Youyou Tu is a natural product medicinal chemist at the
China Academy of Chinese Medical Sciences who made signiﬁ-
cant contribution to the discovery of artemisinin as an antimalarial
drug. Back in the 1960s, malaria was the most common and
widespread parasitic disease in tropical and subtropical regions,
which killed millions of lives annually. Fortunately, China,
under the “whole nation” system, launched a multidisciplinary
drug discovery team that involved hundreds of scientists nation-
wide, including Youyou Tu. Their efforts led to the discovery of
many antimalarial drugs or drug candidates, including artemisinin,
dihydroartemisinin, artemether, and artesunate. Several of
these drugs have been used since then as the standard treatment
for P. falciparum and saved millions of malarial patients
worldwide.
The discovery of artemisinin is a miracle in the history of
Chinese pharmaceutical industry, especially during that special
period of time when China was enduring a particularly difﬁcult
time with endemic poverty and the disastrous culture revolution.
Many elegant reviews have been published recently (e.g., Nat.
Prod. Rep. 2015; 32: 1617–21), walking through the historical
discovery process of artemisinin, and with efforts to ﬁnd insights or
implications both to enlighten the currently much modernized drug
discovery world and to encourage old and young generations of
scientists working with the traditional Chinese medicines (TCMs).16/j.apsb.2016.03.001
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esponsibility of Institute of Materia Medica, Chinese AcThis Feature written by Prof. Zongru Guo is a timely account
highlighting the most important aspects of the artemisinin story,
including the initial discovery of artemisinin as the active
component, subsequent structural characterization, total synthesis,
and structural modiﬁcation, as well as the identiﬁcation and clinical
validation of the most important antimalarial drugs artemether,
artesunate and dihydroartemisinin. From a medicinal chemist’s
viewpoint, this review also provides expert discussions on the
QSAR, structure-based physico–chemical properties, drug-likeness
developments, and formulation studies of artemisinin analogs. As
emphasized, the success of artemisinin was the fruit of collabora-
tive teamwork by a large number of multidisciplinary scientists,
including natural product chemists who identiﬁed the active
compound from natural sources, organic chemists who elucidated
the precise chemical structure, medicinal chemists who tuned the
safety proﬁles through structural optimization, and pharmacologists
and clinicians who made tremendous efforts to validate the effects
of artemisinin and its analogs both in vitro and in vivo. In the
meantime, we have to be aware that the success of artemisinin or
the recognition by the Nobel Prize does not mean that the ﬁght
against the tropical disease is over; instead, we have to work much
harder to ﬁnd new and further improved treatments since drug
resistance to artemisinin therapies has already been reported.Guest editor of Feature
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